SEC Form 5 · accession 0001209191-17-011307
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kimberly J Popovits
Officer — President and CEO · Director
Period of report
Dec 31, 2016
Accepted (ET)
Feb 15, 2017 · 8:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 7, 2016 | G | 3,262 | $0.00 | D | 56,358 | D | |
| Common Stock | Dec 8, 2016 | G | 900 | $0.00 | D | 55,458 | D | |
| Common Stock | holding | — | — | — | 12,298 | I | Held by UBS for Benefit of Kimberly Popovits | |
| Common Stock | holding | — | — | — | 16,825 | I | Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee. | |
| Common Stock | holding | — | — | — | 200,851 | I | Held by the Popovits 2010 Trust |
Table II — derivative securities
No Table II lines on this filing.